Pediatric Zylet Safety and Efficacy Study

NCT00420628 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

108

Enrollment

INDUSTRY

Sponsor class

Conditions

Chalazion
Hordeolum

Interventions

DRUG: loteprednol etabonate/tobramycin opthalmic suspension
DRUG: vehicle

Sponsor

Bausch & Lomb Incorporated